Complete objective response, stable for 5 years, with the Di Bella Method, of multiple-metastatic carcinoma of the breast

Giuseppe Di Bella, Biagio Colori, Rosilde Toscano

Research output: Contribution to journalArticle

Abstract

Breast cancer is the most common cancer and the leading cause of cancer death among women. Despite all efforts, about 11,939 deaths and 50,000 new diagnoses for breast cancer were estimated among Italian women in 2016. Therefore new approaches are needed to improve the survival and higher remission rates. We present a case of a woman with carcinoma of the breast and multiple metastases after right mastectomy, axillary dissection, repeated cycles of chemo and radiotherapy, and estrogen block. Biological method formulated by Prof. L. Di Bella (DBM) produced a complete and stable objective response without toxicity. The DBM includes antiproliferative molecules, such as somatostatin, prolactin and estrogen inhibitors together with differentiating and apoptotic molecules such as melatonin (MLT), Retinoids, Vitamin E, D3, Vit. C, Calcium, Amino sugars, associated with metronomic microdoses of chemotherapy drugs. The blood tests did not show any damage but a progressive reduction of Prolactin, Estradiol, and IGF1, and continuing low levels of GH. The objective result of this case, in the absence of toxicity, demonstrates the efficacy of the treatment and is in agreement with the positive results already published on the use of the DBM. Not requiring hospital or day hospital admission, and with no significant toxicity, the DBM avoided the significant side effects of chemo- and radiotherapy. We believe that this case can encourage more interest and more in-depth studies on the possibilities that have been opened up in oncology by the DBM treatment of the metastatic breast cancer.

Original languageEnglish
Pages (from-to)401-407
Number of pages7
JournalNeuroendocrinology Letters
Volume38
Issue number6
Publication statusPublished - Dec 2017

Fingerprint

Breast Neoplasms
Prolactin
Estrogens
Radiotherapy
Amino Sugars
Drug Therapy
Cholecalciferol
Mastectomy
Retinoids
Hematologic Tests
Melatonin
Somatostatin
Vitamin E
Dissection
Cause of Death
Estradiol
Neoplasms
Neoplasm Metastasis
Calcium
Survival

Keywords

  • Adult
  • Antineoplastic Agents/therapeutic use
  • Breast Neoplasms/drug therapy
  • Carcinoma, Ductal, Breast/drug therapy
  • Cyclophosphamide/therapeutic use
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Complications, Neoplastic/drug therapy
  • Remission Induction/methods
  • Retinoids/therapeutic use
  • Treatment Outcome
  • Vitamin E/therapeutic use

Cite this

Complete objective response, stable for 5 years, with the Di Bella Method, of multiple-metastatic carcinoma of the breast. / Di Bella, Giuseppe; Colori, Biagio; Toscano, Rosilde.

In: Neuroendocrinology Letters, Vol. 38, No. 6, 12.2017, p. 401-407.

Research output: Contribution to journalArticle

@article{8919f7cd22604c24b3aa69dde1882f1c,
title = "Complete objective response, stable for 5 years, with the Di Bella Method, of multiple-metastatic carcinoma of the breast",
abstract = "Breast cancer is the most common cancer and the leading cause of cancer death among women. Despite all efforts, about 11,939 deaths and 50,000 new diagnoses for breast cancer were estimated among Italian women in 2016. Therefore new approaches are needed to improve the survival and higher remission rates. We present a case of a woman with carcinoma of the breast and multiple metastases after right mastectomy, axillary dissection, repeated cycles of chemo and radiotherapy, and estrogen block. Biological method formulated by Prof. L. Di Bella (DBM) produced a complete and stable objective response without toxicity. The DBM includes antiproliferative molecules, such as somatostatin, prolactin and estrogen inhibitors together with differentiating and apoptotic molecules such as melatonin (MLT), Retinoids, Vitamin E, D3, Vit. C, Calcium, Amino sugars, associated with metronomic microdoses of chemotherapy drugs. The blood tests did not show any damage but a progressive reduction of Prolactin, Estradiol, and IGF1, and continuing low levels of GH. The objective result of this case, in the absence of toxicity, demonstrates the efficacy of the treatment and is in agreement with the positive results already published on the use of the DBM. Not requiring hospital or day hospital admission, and with no significant toxicity, the DBM avoided the significant side effects of chemo- and radiotherapy. We believe that this case can encourage more interest and more in-depth studies on the possibilities that have been opened up in oncology by the DBM treatment of the metastatic breast cancer.",
keywords = "Adult, Antineoplastic Agents/therapeutic use, Breast Neoplasms/drug therapy, Carcinoma, Ductal, Breast/drug therapy, Cyclophosphamide/therapeutic use, Female, Humans, Pregnancy, Pregnancy Complications, Neoplastic/drug therapy, Remission Induction/methods, Retinoids/therapeutic use, Treatment Outcome, Vitamin E/therapeutic use",
author = "{Di Bella}, Giuseppe and Biagio Colori and Rosilde Toscano",
year = "2017",
month = "12",
language = "English",
volume = "38",
pages = "401--407",
journal = "Neuroendocrinology Letters",
issn = "0172-780X",
publisher = "Maghira and Maas Publications",
number = "6",

}

TY - JOUR

T1 - Complete objective response, stable for 5 years, with the Di Bella Method, of multiple-metastatic carcinoma of the breast

AU - Di Bella, Giuseppe

AU - Colori, Biagio

AU - Toscano, Rosilde

PY - 2017/12

Y1 - 2017/12

N2 - Breast cancer is the most common cancer and the leading cause of cancer death among women. Despite all efforts, about 11,939 deaths and 50,000 new diagnoses for breast cancer were estimated among Italian women in 2016. Therefore new approaches are needed to improve the survival and higher remission rates. We present a case of a woman with carcinoma of the breast and multiple metastases after right mastectomy, axillary dissection, repeated cycles of chemo and radiotherapy, and estrogen block. Biological method formulated by Prof. L. Di Bella (DBM) produced a complete and stable objective response without toxicity. The DBM includes antiproliferative molecules, such as somatostatin, prolactin and estrogen inhibitors together with differentiating and apoptotic molecules such as melatonin (MLT), Retinoids, Vitamin E, D3, Vit. C, Calcium, Amino sugars, associated with metronomic microdoses of chemotherapy drugs. The blood tests did not show any damage but a progressive reduction of Prolactin, Estradiol, and IGF1, and continuing low levels of GH. The objective result of this case, in the absence of toxicity, demonstrates the efficacy of the treatment and is in agreement with the positive results already published on the use of the DBM. Not requiring hospital or day hospital admission, and with no significant toxicity, the DBM avoided the significant side effects of chemo- and radiotherapy. We believe that this case can encourage more interest and more in-depth studies on the possibilities that have been opened up in oncology by the DBM treatment of the metastatic breast cancer.

AB - Breast cancer is the most common cancer and the leading cause of cancer death among women. Despite all efforts, about 11,939 deaths and 50,000 new diagnoses for breast cancer were estimated among Italian women in 2016. Therefore new approaches are needed to improve the survival and higher remission rates. We present a case of a woman with carcinoma of the breast and multiple metastases after right mastectomy, axillary dissection, repeated cycles of chemo and radiotherapy, and estrogen block. Biological method formulated by Prof. L. Di Bella (DBM) produced a complete and stable objective response without toxicity. The DBM includes antiproliferative molecules, such as somatostatin, prolactin and estrogen inhibitors together with differentiating and apoptotic molecules such as melatonin (MLT), Retinoids, Vitamin E, D3, Vit. C, Calcium, Amino sugars, associated with metronomic microdoses of chemotherapy drugs. The blood tests did not show any damage but a progressive reduction of Prolactin, Estradiol, and IGF1, and continuing low levels of GH. The objective result of this case, in the absence of toxicity, demonstrates the efficacy of the treatment and is in agreement with the positive results already published on the use of the DBM. Not requiring hospital or day hospital admission, and with no significant toxicity, the DBM avoided the significant side effects of chemo- and radiotherapy. We believe that this case can encourage more interest and more in-depth studies on the possibilities that have been opened up in oncology by the DBM treatment of the metastatic breast cancer.

KW - Adult

KW - Antineoplastic Agents/therapeutic use

KW - Breast Neoplasms/drug therapy

KW - Carcinoma, Ductal, Breast/drug therapy

KW - Cyclophosphamide/therapeutic use

KW - Female

KW - Humans

KW - Pregnancy

KW - Pregnancy Complications, Neoplastic/drug therapy

KW - Remission Induction/methods

KW - Retinoids/therapeutic use

KW - Treatment Outcome

KW - Vitamin E/therapeutic use

UR - https://www.ncbi.nlm.nih.gov/pubmed/29298280

M3 - Article

VL - 38

SP - 401

EP - 407

JO - Neuroendocrinology Letters

JF - Neuroendocrinology Letters

SN - 0172-780X

IS - 6

ER -